Close

News

InnoCare Pharma Signs $3.35 Billion Strategic Licensing Agreement with Eli Lilly

Chinese biopharmaceutical company InnoCare Pharma has entered into a strategic research collaboration and licensing agreement with Eli Lilly and Company to develop new medicines, with total potential payments reaching approximately $3.35 billion. Agreement Structure and Financial Terms Under the terms of...

How Tamper-Evident Packaging Protects Pharmaceutical Supply Chains: Case Studies in Brand Protection

Counterfeit pharmaceuticals represent one of the most dangerous threats facing the healthcare industry today. These fake medications endanger patient lives, drain revenue from legitimate manufacturers and undermine trust in pharmaceutical brands. Protecting your supply chain requires more than standard...

Novartis and BoomRay Enter Global License Agreement for Preclinical Radioligand Therapy Asset

Novartis has entered into an exclusive global license agreement with BoomRay Pharmaceuticals for an undisclosed preclinical radioligand therapy asset, with total potential payments to BoomRay reaching up to $900 million. Announced on September 22, 2026, this radioligand license deal brings...

Roche Obesity Drug Enicepatide Delivers 15.5% Weight Loss and Blood Sugar Reduction in Mid-Stage Trial

Swiss pharmaceutical company Roche has announced that its experimental dual-acting obesity drug, enicepatide, helped overweight or obese patients living with type 2 diabetes achieve an average body weight reduction of 15.5% while also significantly lowering blood sugar levels in...

UK Launches £45M Research Partnership Funding and Unveils First Workplace Health System Plan

The UK's National Institute for Health and Care Research (NIHR) has opened the first funding round for its Strategic Infrastructure Partnerships programme, inviting applications for a share of £45 million aimed at accelerating the translation of early-stage medical discoveries...

Temperature Mapping for GMP Warehouses: What Auditors Expect to See

Temperature mapping is one of the most frequently inspected elements of GMP warehouse qualification, and the gap between documentation that satisfies an auditor and documentation that raises questions is often a matter of how well the mapping study was...

ACHEMA 2027 Strengthens India Process Industry Collaboration

DECHEMA, EEPC INDIA and Messe Frankfurt India brought together more than 200 industry leaders, business stakeholders and professionals from India’s process, chemical, pharmaceutical and engineering sectors at a Networking Evening in New Delhi on 8 September 2026. Held at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »